Skip to Content
Stock Analyst Update

Solid Q1 at Coke, Yet No Changes to Fair Value Estimate

The strategic framework is intact following IPO plans at Coca-Cola Beverages Africa.

Mentioned:

With the market seeming to shrug off worries about wide-moat Coca-Cola’s (KO) tax quandary heading into its first-quarter earnings (appropriately so, in our view), we believe investors were squarely focused on signs of business recovery amid the pandemic and progress on strategic initiatives. The report was constructive on both fronts, with results that were ahead of FactSet consensus on the top and bottom lines and an announcement of plans to monetize one of Coke’s largest bottling investments—Coca-Cola Beverages Africa—via IPO. This aligns with Coke’s strategic belief in intermediation along its value chain, and while transaction details aren’t public, we don’t expect a material valuation impact. After weighing the quarter’s results, we don’t plan to materially change our $55 fair value estimate, and while the recent share rally has eroded the margin of safety we saw earlier in the year, we’d watch for any pullbacks.

Revenue came in at $9.02 billion, up 5% year over year and 6% organically (5% volume and 1% price/mix). While calendar shifts (five more days in the quarter) made a nontrivial contribution to growth, underlying performance was encouraging and improved sequentially throughout the quarter. In fact, March 2021 volumes were at parity with 2019 prepandemic levels. With March 2020 stockpiling making this the toughest comparable quarter, we expect easier comps and improving mobility to support high-single-digit organic growth in 2021 despite vaccination challenges in key markets in Europe and Latin America.

Adjusted operating margin was commendable, up 40 basis points to 31%. While some of the margin benefits remain specific to the pandemic (lower trade, marketing, and travel spending, for example), we believe there will be ample offsets as costs come back into the system.

The potential for an unfavorable resolution in its tax dispute with the IRS around transfer pricing remains a cost hang, but we believe any cash outlay will be reasonable. 

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Nicholas Johnson does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.